US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MU $934.27 ▼-4.98% MSFT $530.14 ▼-0.16% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.5389 +0.0071 (+1.34%)
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript ↗
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
HeartBeam Inc (NASDAQ:BEAT) Reports Q4 2025 Earnings, Highlights FDA Clearance and Commercial Launch ↗
Via Chartmill
News headline image
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study ↗
HeartBeam starts ALIGN-ACS study to validate 3D ECG for home-based heart attack detection. 
Via Stocktwits
News headline image
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home ↗
HeartBeam and Mount Sinai partner to develop AI-ECG algorithms for remote heart attack assessment. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market ↗
HeartBeam partners with ClearCardio to commercialize its 3D ECG tech for preventive cardiac care. 
Via Stocktwits
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules March 12 Conference Call to Review Q4 and Full-Year 2025 Results
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio as First Customer and Strategic Investor
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target on Commercialization Momentum
Via Investor Brand Network
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer
Via Investor Brand Network
News headline image
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – FDA Clearance for HeartBeam Inc. (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
Via Investor Brand Network
Topics Intellectual Property
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
From HeartBeam, Inc.
Via Business Wire
News headline image
Wondering what's happening in today's after-hours session? ↗
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >